⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
NRXP
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
globenewswire.com
NRXP
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
globenewswire.com
NRXP
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
NRXP
Form 8-K
sec.gov
NRXP
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
globenewswire.com
NRXP
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
globenewswire.com
NRXP
Form 8-K
sec.gov
NRXP
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
globenewswire.com
NRXP
Form 8-K
sec.gov
NRXP